About the company

Thank you for visiting AffyXell Therapeutics Co., Ltd.

AffyXell Therapeutics Co., Ltd. (CEO: Seungho Jeon)
is a next-generation cell & gene therapy development company founded
in January 23rd, 2020 as a joint venture by Daewoong Pharmaceuticals
and Avacta Life Science, U.K.

We are developing next generation cell & gene therapeutics (AFX platform technology) for optimized for immunomodulation of diseases. The AFX platform technology is new modality of cell & gene therapeutics that based on advanced mesenchymal stem cells which to overcome the limitations of tissue-derived mesenchymal stem cells and adopted Affimer platform technology by genetic manipulations for improve immunomodulation function.

Company Overview


Sengho Jeon

Established on

January 23rd, 2020



Headquarters) Gimhae Biomedical Industry Promotion Institute Techno Town #404, 80-59 Golden Route, Juchon-myeon, Gimhae-si, Gyeongsangnam-do
AFX platform R&D center) Gwanggyo, Gwanggyojungang-ro 338, Umi Newv Knowledge Industry Center B-205, Suji-gu, Yongin-si, Gyeonggi-do


Cell & gene therapeutics for treating immune and inflammatory diseases

Major Business

Development of
cell & gene therapeutics

Research consulting


About the CI

Corporate Identity

  • “Affy-“ comes from Latin, meaning trust, relationship, and marriage, and signifies the relationship and merge between Daewoong Pharmaceutical's platform and Avacta's platform.
  • “X” represents the chromosomes in our body, and the secretion by X indicates the expression of new substances with medicinal and therapeutic properties.
  • By using “X” instead of C in the word “Cell”, it contains the will to create a novel type of cell that has never existed before through gene introduction.


Arrangement, internal spacing, minimum space and size of the logo are under strict regulation, and an accurate digital artwork must be always used to avoid damaging the logo.
For effective use of the logo, it is necessary to secure its independence from other elements around it to maintain its unique identity.
When used in various media, a minimal spacing must be kept for the margin encircling the logo so that other characters or graphic elements cannot invade.

Color System

Color is an important factor that directly affects the brand image of AffyXell Therapeutics, so be sure to follow the below.
Various examples have been made for primary colors, secondary colors, and special printing applications.

Main color
C0 + M0 + Y0 + K90 R62 + G58 + B57
C0 + M50 + Y85 + K0 R241 + G148 + B46
C0 + M75 + Y85 + K0 R235 + G97 + B42
C0 + M90 + Y85 + K0 R232 + G56 + B40
Sub color
C95 + M80 + Y60 + K45 R7 + G43 + B60
C18 + M17 + Y20 + K0 R216 + G209 + B202

Company View